Skip to main content

Table 2 The association of gene expression of PFKFB family members with survival in oral cancer patients from TCGA database

From: Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma

Variable

ROC

No. (%)

CHR (95% CI)

p value*

AHR (95% CI)

p value†

Overall survival

 PFKFB1

Low

265 (99.6)

1

 

1

 

High

1 (0.4)

5.33 (0.73–38.66)

0.098

4.25 (0.59–30.89)

0.153

 PFKFB2

Low

210 (78.9)

1

 

1

 

High

56 (21.1)

1.20 (0.77–1.86)

0.421

1.28 (0.82–2.00)

0.274

 PFKFB3

Low

25 (9.4)

1

 

1

 

High

241 (90.6)

2.77 (1.02–7.51)

0.046

1.93 (0.70–5.31)

0.201

 PFKFB4

Low

164 (61.7)

1

 

1

 

High

102 (38.3)

1.21 (0.83–1.75)

0.323

1.13 (0.78–1.64)

0.519

Progression-free interval survival

 PFKFB1

Low

71 (26.7)

1

 

1

 

High

195 (73.3)

1.18 (0.75–1.84)

0.480

1.22 (0.78–1.92)

0.381

 PFKFB2

Low

243 (91.4)

1

 

1

 

High

23 (8.6)

1.15 (0.60–2.20)

0.680

1.32 (0.67–2.59)

0.418

 PFKFB3

Low

240 (90.2)

1

 

1

 

High

26 (9.8)

2.14 (1.25–3.65)

0.005

1.85 (1.08–3.19)

0.025

 PFKFB4

Low

203 (76.3)

1

 

1

 

High

63 (23.7)

1.35 (0.88–2.05)

0.166

1.38 (0.91–2.11)

0.133

Disease-free interval survival

 PFKFB1

Low

241 (95.3)

1

 

1

 

High

12 (4.7)

2.20 (0.50–9.67)

0.295

2.24 (0.51–9.84)

0.286

 PFKFB2

Low

201 (79.4)

1

 

1

 

High

52 (20.6)

21.62 (0.00–673172.18)

0.560

535,827.78 (0.00-)

0.987

 PFKFB3

Low

225 (88.9)

1

 

1

 

High

28 (11.1)

1.82 (0.64–5.21)

0.264

1.92 (0.66–5.56)

0.229

 PFKFB4

Low

194 (76.7)

1

 

1

 

High

59 (23.3)

1.61 (0.59–4.36)

0.350

1.51 (0.55–4.15)

0.419

Disease-specific survival

 PFKFB1

Low

16 (20.8)

1

 

1

 

High

61 (79.2)

1.58 (0.64–3.93)

0.325

1.38 (0.55–3.44)

0.490

 PFKFB2

Low

3 (3.9)

1

 

1

 

High

74 (96.1)

1.45 (0.84–2.50)

0.188

1.51 (0.87–2.63)

0.146

 PFKFB3

Low

63 (81.8)

1

 

1

 

High

14 (18.2)

2.74 (1.54–4.87)

0.001

2.43 (1.36–4.37)

0.003

 PFKFB4

Low

35 (45.5)

1

 

1

 

High

42 (54.5)

1.35 (0.80–2.28)

0.259

1.43 (0.85–2.41)

0.184

  1. CI confidence interval, CHR crude hazard ratio, AHR adjusted hazard ratio †p values were adjusted for cell differentiation (moderate + poor vs. well) and AJCC pathological stage (stage III + IV vs stageI + II) by multivariate Cox’s regression
  2. *p values were estimated by Cox’s regression